Cargando…

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19

Detalles Bibliográficos
Autores principales:	HAFEEZ, ZEESHAN, ZEESHAN, ABEER, SHAHID, SANA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Critical Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503213/ http://dx.doi.org/10.1016/j.chest.2021.07.636

Ejemplares similares

SHAKEN, NOT STIRRED: HIGH FREQUENCY PERCUSSIVE VENTILATION AS A SALVAGE THERAPY IN SEVERE ARDS DUE TO COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2021)

ENDOTRACHEAL INTUBATION TIMING AND OUTCOME IN ARDS DUE TO COVID-19 INFECTION
por: PEREZ GUTIERREZ, VICTOR, et al.
Publicado: (2021)

PROPOFOL-RELATED INFUSION SYNDROME IN A PATIENT WITH ARDS SECONDARY TO THE NOVEL COVID-19
por: FREEMAN, HOWARD, et al.
Publicado: (2021)

SEVERE HYPONATREMIA AS A MANIFESTATION OF A NEUROLOGIC DISORDER ASSOCIATED WITH THE COVID-19 VACCINE
por: MENCHACA, KRISTINA, et al.
Publicado: (2022)

OUTCOMES OF EXTRACORPOREAL MEMBRANE OXYGENATION IN ARDS DUE TO COVID-19: COMPARISON OF THE FIRST AND THE SECOND WAVE
por: REDDY, ROHIT, et al.
Publicado: (2021)

EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) VS CONVENTIONAL MECHANICAL VENTILATION FOR SEVERE ACUTE RESPIRATORY FAILURE DUE TO COVID-19: A MULTICENTER MATCHED COHORT STUDY
por: WHITMORE, SAGE, et al.
Publicado: (2022)

USE OF CRESCENT JUGULAR CATHETER IN PATIENTS WITH SEVERE COVID-19 REQUIRING EXTENDED ECMO SUPPORT
por: CHAN, VERNON, et al.
Publicado: (2021)

RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH COVID-19 REQUIRING ECMO IS PREDICTIVE OF LONGER ECMO COURSE BUT NOT INCREASED MORTALITY
por: TAYLOR, LAUREN, et al.
Publicado: (2021)

DOES EXTRACORPOREAL MEMBRANE OXYGENATION SAVE LIVES IN COVID-19-ASSOCIATED SEVERE ARDS
por: VARGHESE, JOBIN, et al.
Publicado: (2021)

CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS MEETING VENO-VENO ECMO ELIGIBILITY CRITERIA RECEIVING ECMO VS CONVENTIONAL THERAPY ALONE
por: SIPSEY, LYNN, et al.
Publicado: (2022)

RIGHT VENTRICULAR DYSFUNCTION IN A COVID-19 ECMO POPULATION
por: HABIB, NAOMI, et al.
Publicado: (2021)

RALE SCORE AS A PROGNOSTICATION TOOL FOR PATIENTS WITH COVID-19 ON ECMO
por: PADHYE, AKHILESH, et al.
Publicado: (2021)

VV-ECMO IN PATIENTS WITH COVID-19: SURVIVAL PREDICTION SCORE COMPARISON
por: SHAH, ROSHAN, et al.
Publicado: (2021)

MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022)

CA N'EST PAS DU GÂTEAU: CHALLENGES OF MECHANICAL VENTILATION IN A PATIENT WITH ARDS DUE TO COVID-19 INFECTION AND TRACHEOMEGALY
por: KHALID, FAIZA, et al.
Publicado: (2021)

BLOODSTREAM INFECTIONS IN PATIENTS WITH COVID-19 TREATED WITH EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
por: SHARAYAH, AHMAD, et al.
Publicado: (2022)

EXTRA-CORPOREAL CARBON DIOXIDE REMOVAL IN COVID-19 ARDS
por: Boparai, Sukhmani, et al.
Publicado: (2020)

PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)

CHANGES IN ARDS MANAGEMENT AS A RESULT OF THE COVID-19 PANDEMIC
por: MACHURICK, MAXWELL, et al.
Publicado: (2021)

CIRCULATING DAMAGE-ASSOCIATED MOLECULAR PATTERNS (DAMPS) AS PROGNOSTIC MARKERS OF DISEASE SEVERITY IN PATIENTS WITH COVID-19 ARDS IN THE ICU
por: ALGHANIM, FAHID, et al.
Publicado: (2022)

Clinical characteristics of patients with a risk of pulmonary artery hypertension secondary to ARDS in a high-altitude area
por: Zhu, Peng, et al.
Publicado: (2023)

THE LONG SWEEP: A CASE OF PROLONGED VENO-VENOUS ECMO IN COVID-19 PNEUMONIA
por: BAIN, ALEXANDER, et al.
Publicado: (2021)

COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS
por: White, Kyle, et al.
Publicado: (2020)

ELEVATED D-DIMER PREDICTS DETERIORATION OF ARDS IN PATIENTS WITH COVID-19
por: LOPEZ RUIZ, ARNALDO, et al.
Publicado: (2021)

PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021)

PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA IN COVID-19 ARDS: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

IMMUNE THROMBOCYTOPENIA SECONDARY TO COVID-19
por: AGRAWAL, AVNI, et al.
Publicado: (2021)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
por: Mahida, Rahul Y, et al.
Publicado: (2020)

Tidal changes on CT and progression of ARDS
por: Cereda, Maurizio, et al.
Publicado: (2017)

TELE-ECMO FOR A YOUNG, ACTIVE DUTY SERVICEMEMBER IN A DOMESTIC COVID-19 HOTSPOT
por: ROHRHOFF, NICK, et al.
Publicado: (2021)

A CASE OF PRIAPISM IN A MAN ADMITTED TO THE ICU FOR COVID-19 ARDS
por: ANDERSEN, KARL, et al.
Publicado: (2021)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

COVID-19-RELATED ARDS PHENOTYPES AND PROGRESSION BETWEEN THEM: A CASE REPORT
por: Steff, Rodney, et al.
Publicado: (2020)

USE OF TISSUE PLASMINOGEN ACTIVATOR IN COVID-19 ARDS: A RETROSPECTIVE CASE SERIES
por: NEMEH, CHRISTOPHER, et al.
Publicado: (2021)

CORRELATION OF C-REACTIVE PROTEIN (CRP) WITH ICU COVID-19 ARDS MORTALITY IN ADULTS
por: CHANDRAN, RAVI T, et al.
Publicado: (2022)

FROM HOME TO ECMO: A CASE OF NEW-ONSET CARDIOMYOPATHY IN A PATIENT WITH POST-COVID-19 INFECTION
por: ADDERLEY, PATTON, et al.
Publicado: (2021)

Effects of Intraosseous Tibial vs. Intravenous Vasopressin in a Hypovolemic Cardiac Arrest Model
por: Fulkerson, Justin, et al.
Publicado: (2016)

ARDS following oesophagectomy: a comparison of two trials
por: Howells, Phillip A, et al.
Publicado: (2017)

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
por: Wadud, Nafisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1au7fsb7q2jp4unpvf38jn9p09